Case Study: Treatment persistence in Crohn’s disease
Check out our case study on Crohn’s disease (CD) treatment outcomes to learn how Prospection helped support the decisions a pharma company made related to strategy, communication, education, and clinical support for its brand. Their data-driven decision process was fuelled by rich insights and real-world evidence generated through the Prospection Platform.
A retrospective review of the persistence of bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population
This study aimed to describe the persistence of biologic disease modifying anti-rheumatic drugs (bDMARDs) in Australian rheumatoid arthritis (RA) patients.
Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
This paper aimed to describe the persistence of treatment with subcutaneous tumor necrosis factor inhibitors (TNFi) adalimumab, etanercept, and golimumab in immune-mediated rheumatic disease (rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis) by treatment sequence (first-line treatment, second-line or further lines of treatment).